[Some issues in the diagnosis and treatment of hyperprolactinemia].
Jin
Zi-Meng
ZM
D000634:Aminoquinolines / Q000627:therapeutic use; D000077465:Cabergoline; D003937:Diagnosis, Differential; D018491:Dopamine Agonists / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000175:diagnosis* / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D010902:Pituitary Gland / Q000378:metabolism / Q000473:pathology; D010911:Pituitary Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood* / Q000187:drug effects / Q000378:metabolism; D015175:Prolactinoma / Q000097:blood / Q000175:diagnosis / Q000473:pathology / Q000628:therapy
D000634:Aminoquinolines; D018491:Dopamine Agonists; D004873:Ergolines; C046650:quinagolide; D011388:Prolactin; D000077465:Cabergoline